Reta

Retatrutide 30 mg

Retatrutide is a triple agonist. It activates GIP, GLP-1 and glucagon receptors at the same time — the most potent of the injectable weight-management peptides currently in research.

What it does

• Appetite suppression across three receptor pathways
• Supports metabolic rate alongside calorie reduction
• Early research shows superior weight-loss outcomes vs dual agonists
• Once-weekly dosing via the cartridge and reusable pen

How it's delivered

30 mg cartridge. Fits the reusable click-pen. Subcutaneous, once weekly. Dose dialled on the pen.

Don't have a pen? Add a Disposable Pen — R125

Takes standard 3 ml cartridges. Or buy the reusable Starter Kit once.